HR Execs on the Move

Amgen

www.amgen.com

 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people`s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world`s leading independent biotechnology companies, has reached millions of patients around the world and is ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.amgen.com
  • One Amgen Center Drive
    Thousand Oaks, CA USA 91320
  • Phone: 805.447.1000

Executives

Name Title Contact Details
Alexander Dabit
 Associate Director - Talent, People, and Culture Profile
Dean Patras
 Chief People Officer Profile
Dean P
 Chief People Officer Profile
Caitlin Zinsser
 VP | Talent Advisor | Corporate Functions Profile
Heidi Trybus
 Senior Talent Acquisition Partner (Consultant) Profile

Similar Companies

Alternatives Technologies Pharma

Alternatives Technologies Pharma Inc. is a Chicoutimi, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Western Oncolytics

Western Oncolytics is developing a new generation of oncolytic viral immunotherapies to help patients accross the globe beat cancer

Simcha Therapeutics

Simcha Therapeutics uses directed evolution to engineer novel cytokines designed to unlock the precision and power of the immune system.

Enthalpy Analytical

Enthalpy Analytical, Inc. is a Durham, NC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Aeglea

With its acquisition of Spyre Therapeutics, Aeglea is shifting its disease focus to inflammatory bowel disease (IBD). Spyre combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for IBD.